REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $133,000 | +1.5% | 29,000 | +52.6% | 0.01% | 0.0% |
| Q2 2021 | $131,000 | -8.4% | 19,000 | -2.5% | 0.01% | -14.3% |
| Q1 2021 | $143,000 | -8.9% | 19,485 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $157,000 | -22.3% | 19,485 | -1.3% | 0.01% | -42.9% |
| Q3 2020 | $202,000 | +43.3% | 19,735 | -6.0% | 0.01% | +75.0% |
| Q2 2020 | $141,000 | +58.4% | 20,985 | +7.1% | 0.01% | +33.3% |
| Q1 2020 | $89,000 | -25.2% | 19,600 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $119,000 | +17.8% | 19,600 | +61.3% | 0.01% | +20.0% |
| Q1 2019 | $101,000 | +48.5% | 12,150 | -0.8% | 0.01% | +25.0% |
| Q4 2018 | $68,000 | -41.4% | 12,250 | -6.8% | 0.00% | -20.0% |
| Q3 2018 | $116,000 | -0.9% | 13,150 | -4.4% | 0.01% | 0.0% |
| Q2 2018 | $117,000 | +64.8% | 13,750 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $71,000 | +29.1% | 13,750 | +27.9% | 0.00% | 0.0% |
| Q4 2017 | $55,000 | -87.7% | 10,750 | -73.9% | 0.00% | -87.0% |
| Q3 2017 | $446,000 | +24.6% | 41,250 | -0.7% | 0.02% | +21.1% |
| Q2 2017 | $358,000 | -10.1% | 41,550 | 0.0% | 0.02% | -9.5% |
| Q1 2017 | $398,000 | -8.5% | 41,550 | 0.0% | 0.02% | -12.5% |
| Q4 2016 | $435,000 | -24.6% | 41,550 | 0.0% | 0.02% | -25.0% |
| Q3 2016 | $577,000 | +27.9% | 41,550 | 0.0% | 0.03% | +18.5% |
| Q2 2016 | $451,000 | – | 41,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |